IRIX CIK: 1006045

Iridex Corp.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
42.3
FY22:
35.8
FY23:
27.5
FY24:
23.6
FY25:
25.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.43
FY22:
6.52
FY23:
6.99
FY24:
5.57
FY25:
3.90
Total assets
Change from FY21 to FY25
millions USD
FY21:
48.7
FY22:
42.3
FY23:
34.4
FY24:
29.1
FY25:
29.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
12.6
FY22:
12.5
FY23:
13.0
FY24:
16.6
FY25:
13.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.7
FY22:
12.6
FY23:
11.9
FY24:
10.5
FY25:
11.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
23.3
FY22:
17.2
FY23:
9.52
FY24:
2.10
FY25:
4.92
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
48.7
FY22:
42.3
FY23:
34.4
FY24:
29.1
FY25:
29.2

All amounts in millions USD Data source:SEC EDGAR